Rosetta Genomics (ROSG) Receives Rescission of Conditional Approval from NYSDOH; Will Not Process CAST PCR-Based Assays in New York
Tweet Send to a Friend
Rosetta Genomics (Nasdaq: ROSG) announces that the Company received notice of rescission of conditional approval from the New York State ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
